Nalan Akgül Babacan

Nalan Akgül Babacan

Auto-generated profile, based on publicly available information

Nalan Akgül Babacan

King Hamad Univ Hosp, Bahrain Oncol Ctr, Dept Oncol, Almuharraq, Bahrain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2021 in Balkan Medical Journal
Verified
Journal Article
Open access
TBTugba Basoglu
Tugba Basoglu
KAKadriye Ebru Akar
Kadriye Ebru Akar
PBPelin Bagci
Pelin Bagci
NBNalan Akgül Babacan
Nalan Akgül Babacan
MÖMehmet Akif Öztürk
Mehmet Akif Öztürk
PYPerran Fulden Yumuk
Perran Fulden Yumuk
Pancreatic ductal adenocarcinoma differs from other solid tumors with its unique immunosuppressive microenvironment and non-immunogenic feature. There are not many studies in the literature investigating the effect of these features on prognosis. To investigate the prognostic value of tissue-resident memory T cells, tumor microenvironment features, and tumor-associated immune cells in resected pancreatic ductal adenocarcinomas. Retrospective cross-sectional study. Of 138 patients diagnosed with pancreatic ductal adenocarcinoma between 2011 and 2018, 81 were included in the study. Specimens from operated patients were reassessed separately as peritumoral and intratumoral areas for tissue resident memory cells and tumor microenvironmental elements (tumor infiltrating lymphocytes, tumor stroma, CD204+ macrophages, PDL1+ immune cells). Disease-free survival and overall survival were defined from the date of operation to the date of recurrence and the date of first diagnosis to the date of death, respectively. If the patient was alive, the last visit date was taken into account. The median age at diagnosis was 63 (range: 40-78). The median follow-up period was 18.9 months (range: 1.4-80.4 months). Median overall survival was 23.7 months (1.4-80.4 months) and median disease-free survival was 10.8 months (1.4-74.4 months). Patients with higher intra-tumoral tissue-resident memory cell counts had a longer survival trend than those having lower values (25.6 months vs. 18 months, respectively, P = .84). According to microenvironmental evaluations, lower stromal score (defined as stroma having less desmoplasia and rich in cells) and presence of peritumoral Crohn’s-like inflammatory response were associated with higher survival (29.2 months vs. 19.7 months for low vs. high stromal scores, respectively, P = .16 and 30.2 months vs. 18.1 months for the presence of Crohn’s-like inflammatory response P = .13). Decreased survival was observed in tumors with increased CD204+ tumor-associated macrophages which were immunosuppressive elements of the microenvironment (12 months vs. 26.3 months for intra-tumoral assessment, P = .29). Tissue-resident memory T cells and other microenvironmental features may be prognostic in resectable pancreatic ductal adenocarcinomas. Further studies with larger cohorts are needed for validation.

1 August 2015
Verified
Journal Article
Closed access
NTNedim Turan
Nedim Turan
MBMustafa Benekli
Mustafa Benekli
OUOlcun umit Unal
Olcun umit Unal
IUIlkay tugba Unek
Ilkay tugba Unek
DTDidem Tastekin
Didem Tastekin
A(Anatolian Society Of Medical Oncology (Asmo)
Anatolian Society Of Medical Oncology (Asmo)

13 June 2022 in Future Oncology
Verified
Journal Article
Closed access
TTTugba Akin Telli
Tugba Akin Telli
MOMehmet Akif Ozturk
Mehmet Akif Ozturk
ÖAÖzkan Alan
Özkan Alan
RHRahib Hasanov
Rahib Hasanov
OKOsman Kostek
Osman Kostek
PYPerran Fulden Yumuk
Perran Fulden Yumuk
Objective: The aim of this study was to investigate quality-of-life (QoL) in breast cancer (BC) patients treated with adjuvant endocrine therapy (AET). Methods: We designed a cross-sectional study ... Plain language summary Breast cancer (BC) remains the most common cancer among women worldwide. Hormone receptor-positive (estrogen receptor- and/or progesterone receptor-positive) BC represents 70...

25 June 2024 in Flora the Journal of Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Closed access
UEUmran Sumeyse Elbahr
Umran Sumeyse Elbahr
HEHakan Erdem
Hakan Erdem
HAHandan Ankarali
Handan Ankarali
CRClark Steven Delos Reyes
Clark Steven Delos Reyes
JPJennie Pastrana
Jennie Pastrana
OSOğuz Reşat SİPAHİ
Oğuz Reşat SİPAHİ

14 March 2022 in Namık Kemal Tıp Dergisi
Verified
Journal Article
Open access
TTTuğba AKIN TELLİ
Tuğba AKIN TELLİ
NBNalan Akgül Babacan
Nalan Akgül Babacan
ÖAÖzkan Alan
Özkan Alan
MÖMehmet Akif Öztürk
Mehmet Akif Öztürk
RHRahib Hasanov
Rahib Hasanov
PYPerran Fulden Yumuk
Perran Fulden Yumuk